The FDA medical officer was once the primary reviewer for Avandia, according to a letter sent to the FDA by Senator Max Baucus Charles Grassley.
The scientist has believed that as far back as 2005 that there was enough evidence for a strong "black box" warning on Avandia about a risk of congestive heart failure according to the senators.
For more go the source of this blog post, here.